CRISPResso2 Tutorial: Quantifying & Visualizing Genome Editing

Added:

Limitations of Amplicon-Based Quantifiers and the Shift to Long-Read and Unbiased Analysis

While CRISPResso2 is a popular standard for analyzing short-read amplicon sequencing data, critics and alternative methodologies highlight several limitations. First, amplicon-based sequencing inherently fails to detect large genomic deletions, translocations, or structural rearrangements caused by CRISPR, resulting in an incomplete safety profile. Second, competing software pipelines like AMPLICAN argue that CRISPResso2 is prone to alignment artifacts, struggles with primer-dimer contamination, and can overestimate editing efficiency by misclassifying sequencing noise as true gene-editing events. To address these shortcomings, researchers increasingly advocate for long-read sequencing (such as PacBio or Nanopore) and unbiased genome-wide detection methods (like GUIDE-seq) to capture the full, unbiased spectrum of on- and off-target editing outcomes.

Fundamental mechanisms of CRISPR-Cas9 genome editing, including double-strand breaks (DSBs) and cellular repair pathways (NHEJ and HDR).
Understanding of Next-Generation Sequencing (NGS) workflows, specifically amplicon sequencing and the structure of FASTQ files.
Basic principles of advanced genome editing techniques, such as Base Editing (transitioning nucleotides) and Prime Editing (using RT-gRNAs).
Elementary concepts in bioinformatics sequence alignment, including reference sequences, indels, and substitution mutations.
Advanced parameter tuning in CRISPResso2 to troubleshoot and correct for sequencing artifacts, PCR errors, or naturally occurring SNPs.
Integrating CRISPResso2 command-line tools into automated, high-throughput computational pipelines for large-scale genetic screens.
Exploring methodologies for off-target editing evaluation, such as GUIDE-seq, CIRCLE-seq, and associated analytical software.
Applying quantified editing data to downstream translational research, such as optimizing therapeutic guide RNAs or evaluating in vivo gene therapy efficiency.
2.8K views44likes1:00:20@LucaPinelloOriginal Release: 2020-05-20

CRISPResso2 is a computational tool developed to analyze genome editing outcomes by processing next-generation sequencing data from CRISPR experiments, enabling researchers to quantify and visualize editing efficiency, distinguish between on-target and off-target effects, and evaluate different genome editing strategies including base editors and prime editors through specialized quantification windows and visualization features.